Melatonin effectively alleviated Aβ1-40-induced ferroptosis through the PI3K/AKT/MDM2/P53 axis (Figure 7), Offering a novel therapeutic strategy for the management of age-related macular degeneration (AMD). The gene discussed is TP53; the disease is age-related macular degeneration.